Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Anzu Special Acquisition Corp I (ANZU) Competitors

Anzu Special Acquisition Corp I logo

ANZU vs. GROV, SPAI, RBOT, APT, MLSS, NTRB, CLGN, COCH, LFWD, and POAI

Should you be buying Anzu Special Acquisition Corp I stock or one of its competitors? The main competitors of Anzu Special Acquisition Corp I include Grove Collaborative (GROV), Safe Pro Group Inc. Common Stock (SPAI), Vicarious Surgical (RBOT), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Nutriband (NTRB), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), ReWalk Robotics (LFWD), and Predictive Oncology (POAI).

Anzu Special Acquisition Corp I vs.

Anzu Special Acquisition Corp I (NASDAQ:ANZU) and Grove Collaborative (NYSE:GROV) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends, profitability and community ranking.

Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Grove Collaborative's net margin of -11.35%. Anzu Special Acquisition Corp I's return on equity of -17.33% beat Grove Collaborative's return on equity.

Company Net Margins Return on Equity Return on Assets
Anzu Special Acquisition Corp IN/A -17.33% 1.37%
Grove Collaborative -11.35%-417.96%-14.19%

Grove Collaborative received 14 more outperform votes than Anzu Special Acquisition Corp I when rated by MarketBeat users.

CompanyUnderperformOutperform
Anzu Special Acquisition Corp IN/AN/A
Grove CollaborativeOutperform Votes
14
100.00%
Underperform Votes
No Votes

Anzu Special Acquisition Corp I has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. Comparatively, Grove Collaborative has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.

Grove Collaborative has a consensus target price of $2.00, indicating a potential upside of 49.25%. Given Grove Collaborative's stronger consensus rating and higher probable upside, analysts clearly believe Grove Collaborative is more favorable than Anzu Special Acquisition Corp I.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anzu Special Acquisition Corp I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Grove Collaborative
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Anzu Special Acquisition Corp I has higher earnings, but lower revenue than Grove Collaborative.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anzu Special Acquisition Corp IN/AN/A$19.23MN/AN/A
Grove Collaborative$259.28M0.20-$43.23M-$0.69-1.94

27.3% of Anzu Special Acquisition Corp I shares are owned by institutional investors. Comparatively, 91.6% of Grove Collaborative shares are owned by institutional investors. 0.7% of Anzu Special Acquisition Corp I shares are owned by company insiders. Comparatively, 13.1% of Grove Collaborative shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Grove Collaborative had 4 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 4 mentions for Grove Collaborative and 0 mentions for Anzu Special Acquisition Corp I. Grove Collaborative's average media sentiment score of 0.59 beat Anzu Special Acquisition Corp I's score of 0.44 indicating that Grove Collaborative is being referred to more favorably in the news media.

Company Overall Sentiment
Anzu Special Acquisition Corp I Neutral
Grove Collaborative Positive

Summary

Grove Collaborative beats Anzu Special Acquisition Corp I on 10 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ANZU vs. The Competition

MetricAnzu Special Acquisition Corp ISurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$32.86M$9.82B$5.11B$8.84B
Dividend YieldN/A1.10%5.05%4.07%
P/E RatioN/A20.26108.8915.88
Price / SalesN/A28.521,233.2287.15
Price / Cash3.7423.2339.9336.27
Price / Book-1.304.856.946.36
Net Income$19.23M$182.72M$119.18M$226.00M

Anzu Special Acquisition Corp I Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ANZU
Anzu Special Acquisition Corp I
N/A$2.20
+2.3%
N/A+104.0%$32.86MN/A0.003
GROV
Grove Collaborative
2.0719 of 5 stars
$1.34
flat
$2.00
+49.3%
-34.8%$52.21M$259.28M-1.93408
SPAI
Safe Pro Group Inc. Common Stock
N/A$4.47
+39.7%
N/AN/A$61.51MN/A0.0011News Coverage
Gap Up
Trading Halted
High Trading Volume
RBOT
Vicarious Surgical
0.9878 of 5 stars
$10.29
+14.0%
$10.25
-0.4%
-26.1%$60.71MN/A-0.973News Coverage
APT
Alpha Pro Tech
N/A$5.38
+2.7%
N/A+11.1%$59.18M$61.23M14.46120
MLSS
Milestone Scientific
2.1908 of 5 stars
$0.71
+4.4%
$1.25
+76.6%
-15.8%$55.15M$9.83M-10.0330Analyst Forecast
Gap Up
NTRB
Nutriband
0.6358 of 5 stars
$4.87
-2.2%
N/A+125.3%$54.11M$2.09M-6.0110
CLGN
CollPlant Biotechnologies
1.8844 of 5 stars
$4.17
-1.7%
$11.00
+164.1%
-24.2%$47.69M$10.96M-2.7070Upcoming Earnings
COCH
Envoy Medical
3.0851 of 5 stars
$2.20
+2.3%
$7.92
+259.8%
+115.0%$43.12M$320,000.000.0034
LFWD
ReWalk Robotics
3.5853 of 5 stars
$1.86
+0.5%
$13.00
+598.9%
N/A$16.39M$13.85M-0.7460
POAI
Predictive Oncology
2.1946 of 5 stars
$0.69
+6.2%
$3.00
+335.4%
-78.2%$4.60M$1.78M-0.2330Analyst Revision
Gap Up

Related Companies and Tools


This page (NASDAQ:ANZU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners